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Abstract
Introduction: Normoglycemic patients undergoing pancreaticoduodenectomy (Whipple procedure) often inquire whether
they will be diabetic postoperatively. There is limited information on this issue. We therefore looked at a more subtle
measurement of long-term glycemic control, hemoglobin A1c (HgbA1c), as a prognostic tool in predicting progression to
diabetes post Whipple. Patients and methods: A retrospective review over a 6-year period of all patients undergoing Whipple
procedures at a single institution was conducted. In all, 27 patients had no prior history of diabetes, complete follow-up, and
measured preoperative HgbA1c values. Postoperative diabetes was defined as the need for oral hypoglycemic agents or
insulin. These charts were analyzed for progression to diabetes after Whipple. Results: Of the 27 patients, 10 were
considered to have postoperative diabetes. The average preoperative HgbA1c value for these patients was 6.39/0.66. This
was statistically different from the 17 patients without postoperative diabetes (average HgbA1c 5.29/0.39, pB/0.001). The
positive predictive value, negative predictive value, sensitivity, and specificity were 82%, 94%, 90%, and 88%, respectively.
Conclusion: This study demonstrates that progression to diabetes is very unlikely after Whipple operation if the preoperative
HgbA1c value is in the normal range. The apparent utility of HgbA1c in predicting postoperative diabetes in this small study
suggests that this laboratory test may be very helpful in counseling patients for Whipple operation.
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Introduction
Pancreaticoduodenectomy (Whipple procedure) has
been viewed as one of the most aggressive surgical
procedures in the abdomen. However, with improve-
ment in instrumentation, antibiotics, and operative
technique, this operation in now routinely perform-
ed with little morbidity at many tertiary care centers.
The mortality rate of this operation is now 13%
in experienced hands. Therefore, patients under-
going Whipple procedure are now concerned about
their quality of life after the surgery. One impor-
tant question asked by normoglycemic patients is
whether they will become diabetic after Whipple
operation.
In order to answer this question in a simple
manner, we examined the utility of hemoglobin A1c
(HgbA1c) in predicting progression to diabetes after
Whipple surgery. Our hypothesis was that the
HgbA1c would be a better indicator of long-term
glycemic control and therefore a more sensitive
marker of subtle glycemic control issues that would
be uncovered after pancreatic surgery.
Patients and methods
All patients undergoing elective pancreatic surgery at
a single institution between December 1998 and
December 2004 were identified using the institution’s
case logging database. A total of 82 patients were
identified in this time period; patients who did not
have preoperative HgbA1c laboratory values available
and those who carried a preoperative diagnosis of
diabetes were excluded. A subgroup analysis of the 27
eligible patients was conducted through review of
both the electronic and paper medical records.
Approval for this study was obtained from the
Institutional Review Board and met all compliance
regulations of the Health Insurance Portability and
Accountability Act of 1996.
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Upon further evaluation of patient symptoms,
surgical treatment, complications, preoperative lab
values, and discharge medications, the 27 patients
were divided into two groups: those with postopera-
tive diabetes (requiring insulin or oral hypoglycemic
agent on discharge) and those patients without post-
operative diabetes.
A Student’s t test was performed on the two sets of
lab values to evaluate statistical differences in pre-
operative HgbA1c lab values between the two groups.
Positive predictive value, negative predictive value,
sensitivity, and specificity were calculated.
Results
Over the 6-year period of review, 27 patients met the
inclusion criteria. Ten of the 27 patients had post-
operative diabetes. The average age of the diabetic
patients identified postoperatively was 67.1 years
(range 5081) and the average age for the 17
nondiabetic patients was 56.7 years (range 2282)
(Table I). There were seven female and three male
patients in the diabetic group and nine female and
eight male patients in the nondiabetic group.
Pathology was grouped into three categories: be-
nign, pancreatic carcinomas, and nonpancreatic car-
cinomas (Table I). The diabetic group had four
patients with benign pathology (two adenomas, one
pancreatitis, one atypia) and six patients with pan-
creatic adenocarcinomas. The nondiabetic group had
2 patients with benign pathology (2 adenomas), 14
pancreatic cancers (10 adenocarcinomas, 2 endocrine
neoplasms, and 2 intraepithelial neoplasms), and 1
patient with nonpancreatic cancer (renal cell carci-
noma invading the duodenum).
The average preoperative HgbA1c value for the
diabetic patients was 6.339/0.66 mg/dl (Figure 1).
The 17 nondiabetic patients had an average pre-
operative HgbA1c of 5.209/0.39 (pB/0.001, by Stu-
dent’s t test). Positive predictive value of a high
HgbA1c was 82% and negative predictive value of a
normal HgbA1c was 94%. Sensitivity and specificity
were 90% and 88%, respectively.
Discussion
HgbA1c is an excellent test that can help to predict
which normoglycemic patients will become diabetic
after Whipple operation. The negative predictive
value of this test is high (94%), suggesting that if the
HgbA1c is normal, the likelihood of diabetes after
Whipple operation is low.
HgbA1c has been used in diabetic patients as a
good indicator of long-term glycemic control [1,2].
Endocrinologists will follow this value along with
blood sugar measurements in patients with diabetes.
Normal HgbA1c values are associated with lower risk
of end organ complications from diabetes [3,4].
Therefore, tight diabetic control, as reflected by a
normal HgbA1c, is the aim of most endocrinologists.
Literature on the progression to diabetes after
pancreatic surgery is very sparse. Studies examining
risk factors for diabetes progression after Whipple
operation have not been done. While this study
represents a small, retrospective review in a single
center, the results are powerful and clinically relevant.
These results suggest that mild abnormalities in
glycemic control can be detected by the HgbA1c
value and this translates into a high likelihood of
progression to frank diabetes with loss of islet cell
mass with pancreatic surgery.
Table I. Demographics, pathology, and surgical complications of
the two groups.
Parameter Diabetic (n/10) Nondiabetic (n/17)
Gender, F:M 7:3 9:8
Mean age (years)
(range)
66.69/10.2
(5081)
56.49/16.8
(2282)
Pathology
Benign
Adenoma 2 2
Pancreatitis 1 0
Atypia 1 0
Pancreatic cancers
Adenocarcinoma 6 10
Endocrine 0 2
Intraepithelial 0 2
Nonpancreatic cancer
Renal cell carcinoma 0 1
Complications
Leak
Bile 1 0
Pancreatic 0 2
Infection 1 2
Bleeding 2 3
Death 1 0
The demographic differences between the two groups are not
statistically significant (p/0.05 by Student’s t test).
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Figure 1. Average HgbA1c preoperative lab values for diabetic and
nondiabetic patients. The difference in preoperative HgbA1c
between the diabetic and nondiabetic group was statistically
significant (pB/0.001). The nondiabetic patients were mainly in
the normal range for HgbA1c lab values (normal range 3.25.6),
while most diabetic patients had predominantly abnormal values.
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Other confounding factors, such as presence of
excess body fat and elevated body mass index, which
can result in insulin resistance [5], have not been
examined in this study. This will be the target of
future work. Our group aims to examine the correla-
tion of islet cell volume in the resected specimen with
glycemic control, in order to investigate the balance of
insulin production and insulin resistance.
In summary, our results suggest that the clinician
can use HgbA1c to counsel normoglycemic patients
before Whipple surgery: if the HgbA1c is in the
normal range, the likelihood of diabetes postopera-
tively is very low. Clearly, this is a retrospective study
with many limitations and further studies with a
larger sample size will be required to further this
finding.
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